Please login to the form below

Not currently logged in


This page shows the latest Inovio news and features for those working in and with pharma, biotech and healthcare.

Inovio hit with FDA hold on COVID-19 vaccine trial

Inovio hit with FDA hold on COVID-19 vaccine trial

The US Food and Drug Administration (FDA) has placed a temporary hold on Inovio Pharmaceuticals’ mid-to-late stage coronavirus vaccine trial. ... Importantly, the clinical hold is not due to the occurrence of any adverse events related to the vaccine,

Latest news

More from news
Approximately 3 fully matching, plus 9 partially matching documents found.

Latest Intelligence

  • COVID-19: the race to find a vaccine COVID-19: the race to find a vaccine

    Inovio Pharmaceuticals began testing its plasmid candidate in humans in April, putting it at the head of a pack of six groups that have DNA vaccines in development.

  • Developing a COVID-19 vaccine Developing a COVID-19 vaccine

    The CEPI has currently initiated eight COVID-19 vaccine developments with Curevac, Inovio Pharmaceuticals, Moderna, Novavax, The University of Hong Kong, The University of Oxford, The University of Queensland and a

  • Deal Watch February 2017 Deal Watch February 2017

    Amendment to 2015 agreement. 80. Inovio Pharmaceuticals/  ApolloBio Corporation. VGX-3100, DNA immunotherapy to treat pre-cancers caused by human papillomavirus (phase II).

  • Pharma deals in August 2015 Pharma deals in August 2015

    AstraZeneca deals. Subject. Headline $m. Inovio. Cancer vaccines. 727. Heptares. HTL 1071 and A2A receptor blocking compounds. ... Acquisition ‐ company. 847. Inovio. AZ/Medimmune. INO‐3112 vaccine in P1/2 for cervical and head &neck cancer.

  • Deal Watch table for September 2013 Deal Watch table for September 2013

    483. BioFire Diagnostics / BioMerieux. Acquisition. Invitro diagnostic company. 450. Inovio Pharma / Roche Holdings.

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs


Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Emre Vural
Sourcing R&D innovation: why pharma companies need to evolve their business models
Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
Gilead Headquarters
The search for effective drug treatments for COVID-19
PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...